GAM Holding’s Arena Pharmaceuticals Inc ARNA Stock Holding History

GAM Holding’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,300	Closed	-$957K	–	366
2021 Q4	$957K	Buy	+10,300	New	+$679K	0.04%	199
2015 Q4	–	Sell	-52,316	Closed	-$997K	–	1162
2015 Q3	$997K	Hold	52,316	–	–	0.02%	693
2015 Q2	$2.42M	Hold	52,316	–	–	0.04%	477
2015 Q1	$2.29M	Buy	52,316 +23,334	+81%	+$1.08M	0.03%	482
2014 Q4	$1M	Sell	28,982 -748	-3%	-$30.4K	0.02%	712
2014 Q3	$1.25M	Buy	29,730 +7,096	+31%	+$317K	0.02%	646
2014 Q2	$1.33M	Sell	22,634 -5,996	-21%	-$378K	0.02%	635
2014 Q1	$1.8M	Buy	28,630 +1,334	+5%	+$88.5K	0.03%	529
2013 Q4	$1.59M	Sell	27,296 -197	-0.7%	-$10.3K	0.03%	502
2013 Q3	$1.45M	Buy	+27,493	New	+$1.85M	0.03%	560

GAM Holding's ARNA Position: Q1 2022 in Review

GAM Holding sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 10,300 shares — an estimated $957K sold.

GAM Holding first reported a position in ARNA in Q3 2013 and held it in 10 quarters. The position peaked at $2.42M in Q2 2015. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

GAM Holding reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
GAM Holding sold 10,300 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $957K.
GAM Holding first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 10 quarters.
GAM Holding's Arena Pharmaceuticals Inc position peaked at $2.42M in Q2 2015.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on GAM Holding's 13F filing for Q1 2022, filed 6 May 2022.